Incidence of Second Primary Malignancies in Patients With Multiple Myeloma Receiving Anti-CD38 Monoclonal Antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
Leuk. Res 2023 Aug 01;131(xx)107324, A Mian, SAA Naqvi, A Ayaz, M Husnain, MA Aljama, GR Mohyuddin, K Koehn, M Mohan, I Bin Riaz, R ChakrabortyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.